An Unusual but Innovative Entrant into Generic Pharmaceutical Manufacturing
The Financial Times reported that Samsung BioLogics, a division of South Korea based Samsung plans...
Read Moreby ferrariadmin | Apr 19, 2012 | Operations management, Pharmaceutical, Life Sciences and Healthcare Supply Chain | 0 |
The Financial Times reported that Samsung BioLogics, a division of South Korea based Samsung plans...
Read More